PolyMorphine: An innovative biodegradable polymer drug for extended pain relief

Journal of Controlled Release

Volumn 162, Issue 3, 2012, Pages 538-544

  Rosario Meléndez, Roselin ^a   Harris, Carolyn L ^a   Delgado Rivera, Roberto ^a   Yu, Lei ^a   Uhrich, Kathryn E ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Biodegradable; Extended release; Morphine; Pain treatment; Polymer; Prodrug

Indexed keywords

BIODEGRADABLE; EXTENDED RELEASE; MORPHINE; PAIN TREATMENT; PRODRUGS;

CELL CULTURE; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYCONDENSATION; POLYMERS;

BIODEGRADABLE POLYMERS;

CARBROMAL; MORPHINE DERIVATIVE; POLYMER; POLYMORPHINE; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABILITY; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYTOCOMPATIBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PAIN; PARAMETERS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

3T3 CELLS; ANALGESICS, OPIOID; ANIMALS; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; MALE; MICE; MICE, INBRED C57BL; MORPHINE; PAIN; POLYMERS;

EID: 84865575428     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.07.033     Document Type: Article

References (49)

1. T. Sakurada, T. Komatsu, and S. Sakurada Mechanisms of nociception evoked by intrathecal high-dose morphine Neurotoxicology 26 2005 801 809
2. R.K. Portenoy, A.A. Sciberras, L. Eliot, G. Loewen, J. Butler, and J. Devane Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza®, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain J. Pain Symptom Manag. 23 2002 292 300
3. A. Vermeire, and J.P. Remon Stability and compatibility of morphine Int. J. Pharm. 187 1999 17 51
4. M.P. Davis Management of cancer pain: focus on new opioid analgesic formulations Am. J. Cancer 5 2006 171 182
5. C.R. King, and A. Khabazian Cancer treatments. AVINZA (morphine sulfate extended-release capsules) Clin. J. Oncol. Nurs. 7 2003 458
6. E.L. Ross, and K. Hahn KADIAN® (morphine sulfate extended-release) capsules for treatment of chronic, moderate-to-severe, nonmalignant pain Int. J. Clin. Pract. 62 2008 471 479
7. N.A. Hagen, M. Thirlwell, J. Eisenhoffer, P. Quigley, Z. Harsanyi, and A. Darke Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL®) in cancer pain J. Pain Symptom Manag. 29 2005 80 90
8. B. Olsson, Z.G. Wagner, P. Mansson, and G. Ragnarsson A gamma scintigraphic study of the absorption of morphine from controlled-release tablets Int. J. Pharm. 119 1995 223 229
9. T. Kim, J. Kim, and S. Kim Extended-release formulation of morphine for subcutaneous administration Cancer Chemother. Pharmacol. 33 1993 187 190
10. J. Chao Retrospective analysis of Kadian® (morphine sulfate sustained-release capsules) in patients with chronic, nonmalignant pain Pain Med. 6 2005 262 265
11. H.S. Smith Enteral controlled-release opioid delivery systems Pain Med. 10 2009 S30 S38
12. G.J. Grant, K. Vermeulen, M.I. Zakowski, M. Stenner, H. Turndorf, and L. Langerman Prolonged analgesia and decreased toxicity with liposomal morphine in a mouse model Anesth. Analg. 79 1994 706 709
13. J.-J. Wang, K.C. Sung, C.-H. Yeh, and J.-Y. Fang The delivery and antinociceptive effects of morphine and its ester prodrugs from lipid emulsions Int. J. Pharm. 353 2008 95 104
14. S. Küchler, N.B. Wolf, S. Heilmann, G. Weindl, J. Helfmann, M.M. Yahya, C. Stein, and M. Schäfer-Korting 3D-wound healing model: influence of morphine and solid lipid nanoparticles J. Biotechnol. 148 2010 24 30
15. E. Polard, P. Le Corre, F. Chevanne, and R. Le Verge in vitro and In vivo evaluation of polylactide and polylactide-co-glycolide microspheres of morphine for site-specific delivery Int. J. Pharm. 134 1996 37 46
16. M.E. Morales, G. López, V. Gallardo, and M.A. Ruiz Oral suspensions of morphine hydrochloride for controlled release: rheological properties and drug release Mol. Pharm. 8 2011 629 634
17. M.E. Morales, V. Gallardo Lara, A.C. Calpena, J. Doménech, and M.A. Ruiz Comparative study of morphine diffusion from sustained release polymeric suspensions J. Control. Release 95 2004 75 81
18. J.L. Arias, A. Gómez-Gallo, Á.V. Delgado, and M.A. Ruiz Kollidon® SR colloidal particles as vehicles for oral morphine delivery in pain treatment Colloids Surf. B: Biointerfaces 70 2009 207 212
19. M. Fernández-Arévalo, J. Alvarez-Fuentes, A. Iruin, and M.A. Holgado In vitro evaluation of a morphine polymeric complex: flowability behavior and dissolution study AAPS PharmSciTech 5 2004 e39
20. M.A. Holgado, A. Iruin, J. Alvarez-Fuentes, and M. Fernández- Arévalo Development and in vitro evaluation of a controlled release formulation to produce wide dose interval morphine tablets Eur. J. Pharm. Biopharm. 70 2008 544 549
21. J. Alvarez-Fuentes, M. Fernández-Arévalo, M.A. Holgado, I. Caraballo, A.M. Rabasco, J.A. Micó, O. Rojas, and A. Ortega-Alvaro Preclinical study of a controlled release oral morphine system in rats Int. J. Pharm. 139 1996 237 241
22. M. Mahkam, and N. Sharifi-Sanjani Preparation of new biodegradable polyurethanes as a therapeutic agent Polym. Degrad. Stab. 80 2003 199 202
23. L. Erdmann, and K.E. Uhrich Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters) Biomaterials 21 2000 1941 1946
24. R.C. Schmeltzer, T.J. Anastasiou, and K.E. Uhrich Optimized synthesis of salicylate-based poly(anhydride-esters) Polym. Bull. 49 2003 441 448
25. R.C. Schmeltzer, K.E. Schmalenberg, and K.E. Uhrich Synthesis and cytotoxicity of salicylate-based poly(anhydride esters) Biomacromolecules 6 2004 359 367
26. A. Prudencio, R.C. Schmeltzer, and K.E. Uhrich Effect of linker structure on salicylic acid-derived poly(anhydride-esters) Macromolecules 38 2005 6895 6901
27. R.C. Schmeltzer, and K.E. Uhrich Synthesis and characterization of antiseptic-based poly(anhydride-esters) Polym. Bull. 57 2006 281 291
28. A. Prudencio, A.L. Carbone, J. Griffin, and K.E. Uhrich A novel approach for incorporation of mono-functional bioactive phenols into polyanhydrides Macromol. Rapid Commun. 30 2009 1101 1108
29. T.J. Anastasiou, and K.E. Uhrich Aminosalicylate-based biodegradable polymers: syntheses and in vitro characterization of poly(anhydride-ester)s and poly(anhydride-amide)s J. Polymer Sci.; Part A: Polymer Chem. 41 2003 3667 3679
30. A.L. Carbone, M. Song, and K.E. Uhrich Iodinated salicylate-based poly(anhydride-esters) as radiopaque biomaterials Biomacromolecules 9 2008 1604 1612
31. Y. Kim, and K.E. Uhrich Synthesis and characterization of 5-aminosalicylic acid based poly(anhydride-esters) by solution polymerization J. Polymer Sci.; Part A: Polymer Chem. 48 2010 6003 6008
32. K. Whitaker-Brothers, and K. Uhrich Investigation into the erosion mechanism of salicylate-based poly(anhydride-esters) J. Biomed. Mater. Res. A 76A 2006 470 479
33. M.L. Johnson, and K.E. Uhrich Concurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly(anhydride-esters) J. Biomed. Mater. Res. A 91A 2009 671 678
34. K. Whitaker-Brothers, and K. Uhrich Poly(anhydride-ester) fibers: role of copolymer composition on hydrolytic degradation and mechanical properties J. Biomed. Mater. Res. A 70A 2004 309 318
35. R.C. Schmeltzer, and K.E. Uhrich Synthesis and characterization of salicylic acid-based poly(anhydride-ester) copolymers J. Bioact. Compat. Polym. 21 2006 123 133
36. A.L. Carbone, and K.E. Uhrich Design and synthesis of fast-degrading poly(anhydride-esters) Macromol. Rapid Commun. 30 2009 1021 1026
37. B.A. Yeagy, A. Prudencio, R.C. Schmeltzer, K.E. Uhrich, and T.J. Cook Characterization and in vitro degradation of salicylate-derived poly(anhydride-ester) microspheres J. Microencapsul. 23 2006 643 653
38. Rosario-Meléndez, R.; Ouimet, M.A.; Uhrich, K.E. accepted for publication. Formulation of salicylate-based poly(anhydride-ester) microspheres for short- and long-term salicylic acid delivery. Polym. Bull. Manuscript.
39. J.T. Williams, M.J. Christie, and O. Manzoni Cellular and synaptic adaptations mediating opioid dependence Physiol. Rev. 81 2001 299 343
40. J. Gerostamoulos, and O.H. Drummer Solid phase extraction of morphine and its metabolites from postmortem blood Forensic Sci. Int. 77 1996 53 63
41. Q.C. Meng, M. Soleded Cepeda, T. Kramer, H. Zou, D.J. Matoka, and J. Farrar High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites by two-step solid-phase extraction J. Chromatogr. B: Biomed. Sci. Appl. 742 2000 115 123
42. R.C. Schmeltzer, M. Johnson, J. Griffin, and K. Uhrich Comparison of salicylate-based poly(anhydride-esters) formed via melt-condensation versus solution polymerization J. Biomater. Sci. Polym. Ed. 19 2008 1295 1306
43. G.P. Achim Mechanisms of polymer degradation and erosion Biomaterials 17 1996 103 114
44. J. Siepmann, and A. Gopferich Mathematical modeling of bioerodible, polymeric drug delivery systems Adv. Drug Deliv. Rev. 48 2001 229 247
45. L.M. Kamendulis, M.R. Brzezinski, E.V. Pindel, W.F. Bosron, and R.A. Dean Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases J. Pharmacol. Exp. Ther. 279 1996 713 717
46. S. Dumitriu Polymeric Biomaterials Second ed. 2002 Mercel Dekker Inc. New York, NY
47. R.A. Lugo, and S.E. Kern Clinical pharmacokinetics of morphine J. Pain Palliat. Care Pharmacother. 16 2002 5 18
48. L.M. Harrison, A.J. Kastin, and J.E. Zadina Opiate tolerance and dependence: receptors, G-proteins, and antiopiates Peptides 19 1998 1603 1630
49. M. Ueda, H. Fau, and U.M. Ueda Mechanisms underlying morphine analgesic tolerance and dependence Front. Biosci. 14 2009 5260 5272